Weight loss: Double-dip EndoBarrier implant deemed safe in new study

April 27, 2012 by MassDevice staff

Patients who have previously undergone implantation and removal of GI Dynamics' EndoBarrier gastrointestinal sleeve for management of obesity are able to undergo re-implantation without complication, a new study finds.

GI Dynamics logo

Patients who have already gone a round with the implanted EndoBarrier weight-loss management implant can double-dip without procedural consequences, according to a new study.

In a study of 19 obese patients who had previously implanted and then removed GI Dynamics' (ASX:GID) EndoBarrier gastrointestinal sleeve, all were able to undergo re-implantation with "no procedure-related complications," according to a press release.

Sign up to get our free newsletters delivered right to your inbox.

"The efficacy of first-time EndoBarrier therapy in weight loss and blood sugar control have been well established, and these results demonstrate that EndoBarrier can be safely re-implanted in patients who have previously undergone treatment with the device," Dr. Alex Escalona, who presented the results during an oral session of the 5th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders in Barcelona, said in prepared remarks.

"Re-implantation of the EndoBarrier may facilitate additional weight loss and improvements in diabetes and other co-morbid conditions, and additional studies evaluating these clinical benefits are ongoing," he added.